Estrella Immunopharma (Estrella Immunopharma) Receivables Turnover : 0.00 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Estrella Immunopharma Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Estrella Immunopharma's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Estrella Immunopharma's average Accounts Receivable for the three months ended in Mar. 2024 was $0.00 Mil.

Estrella Immunopharma Receivables Turnover Historical Data

The historical data trend for Estrella Immunopharma's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Estrella Immunopharma Receivables Turnover Chart

Estrella Immunopharma Annual Data

Trend

Jun21

Receivables Turnover

Estrella Immunopharma Quarterly Data
	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Estrella Immunopharma's Receivables Turnover

For the Biotechnology subindustry, Estrella Immunopharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Estrella Immunopharma's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Estrella Immunopharma's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Estrella Immunopharma's Receivables Turnover falls into.

Estrella Immunopharma Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Estrella Immunopharma's Receivables Turnover for the fiscal year that ended in Jun. 2021 is calculated as

	Receivables Turnover (A: Jun. 2021 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Jun. 2021 )	/ (	(Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: Jun. 2021 ))	/	count )
=	0	/ (	(	+	0)	/	1 )
=	0	/	0
=	N/A

Estrella Immunopharma's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Estrella Immunopharma (NAS:ESLA) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Estrella Immunopharma Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Estrella Immunopharma's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Estrella Immunopharma (Estrella Immunopharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Estrella Immunopharma Inc (NAS:ESLA) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

5858 Horton Street, Suite 170, Emeryville, CA, USA, 94608

Website

https://www.estrellabio.com

Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Estrella Immunopharma (Estrella Immunopharma) Headlines

No Headlines